CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-07). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2350 · Search date 2026-08-07 · Methodology v0.7

Intravenous glutathione,
does it really help with Whole-body skin lightening?

30-Second Summary
D
Evidence Grade D · 28 · Safety warning
A direct human study found no significant lightening difference and recorded serious adverse effects
The direct study stopped treatment for abnormal liver tests in eight participants and anaphylaxis in one. Regulatory reviews also list reports of Stevens-Johnson syndrome, toxic epidermal necrolysis, and kidney dysfunction.
What the
research shows
The grade is D. A nonrandomized saline-controlled study matched on age and skin color measured skin tone after intravenous administration. Fifty entered but only 32 completed; visual improvement occurred in 6/16 (37.5%) with a glutathione combination infusion and 3/16 (18.7%) with saline, P=0.054. Only one participant maintained improvement at six months.
What the
ads claim
Korean clinics widely sell intravenous glutathione as a self-pay “white jade” infusion and publish prices. Distribution is not efficacy evidence. The detailed authorization wording in the cited Korean policy-briefing document could not be verified and was not used for the grade.
*

Useful facts when choosing a product

  • One nonrandomized age- and skin-color-matched saline-controlled intravenous study directly assessed skin tone; oral and topical evidence was excluded.
  • The endpoint was visual Taylor hyperpigmentation grading, not an instrumented melanin index; all skin-tone measures here are surrogates.
  • Multiple Korean clinics market and sell intravenous glutathione for cosmetic skin lightening.
Gap Measurement · Verdict 2350 · D 28
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Zubair and colleagues enrolled 25 women aged 25 to 47 who were willing to pay into the active group and assigned an age- and skin-color-matched control for each participant to saline. This was a nonrandomized matched saline-controlled study with twice-weekly treatment for six weeks, 12 infusions total. GSH Detox forte contained glutathione 1,200 mg, vitamin C, and 35 mg hydrolyzed collagen. Two non-sun-exposed sites were assessed with Taylor color cards. Completer results were 6/16 versus 3/16, P=0.054. Oral, buccal, and topical studies were excluded from efficacy assessment because their routes differ.

02

Why this is classified as D (28)

A direct human study exists, but its skin-tone result was null and it had completer analysis, heavy attrition, small sample, and short duration, giving D with 28 points.

Counterpoint. The small imprecise study does not exclude every possible lightening effect.

Rejudgment record. Cross-check applied — Null direct nonrandomized matched saline-controlled intravenous study with completer analysis, 36% attrition, small sample, and short duration

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE0Null
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Skin-tone improvement from intravenous glutathioneDCompleter rates were 37.5% versus 18.7%, P=0.054.
Skin lightening from oral or topical glutathione?Different administration routes were not graded in this verdict.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Zubair S·Hafeez S·Mujtaba G. 2016/2017Nonrandomized age- and skin-color-matched saline-controlled completer analysis16Not reportedSkin tone on the Taylor hyperpigmentation scale6/16 (37.5%) versus 3/16 (18.7%), P=0.054; one participant retained improvement at six months.Only direct intravenous skin-lightening study
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-08-07).

Zubair S, Hafeez S, Mujtaba G. Efficacy of intravenous glutathione vs. placebo for skin tone lightening. J Pak Assoc Dermatol. 2016;26(3):177-181. DOI: 10.66344/jpad.v26i3.18.
checked
US Food and Drug Administration. Pharmacy Compounding Advisory Committee Meeting Transcript, June 8, 2022: Glutathione for skin lightening.
checked
Reference 3
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-07 · Corrections: none

Cite this verdict

Intravenous glutathione x skin lightening Evidence Grade D card
[Chamgap] Intravenous glutathione x skin lightening — Evidence Grade D·28. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/intravenous-glutathione-skin-lightening/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.